NSCLC Adjuvant Targeted Therapy

Sort by:
Relevance Thumbs Up Comments Views Newest Oldest
07:07

Lung Cancer Europe (LuCE)

Treatment Approaches in Early Stage and Locally Advanced NSCLC: Impact of Emerging Targeted Agents, SBRT, and IO

FEATURING Simon Ekman
  • 172 views
  • May 24, 2021
15:14

Ani Balmanoukian

Osimertinib in Resected EGFRm NSCLC: Outcomes From ADAURA Trial, Overview of TKI Class

  • 282 views
  • May 20, 2021
  • 1
08:52

Susanne Arnold

EGFR-Mutated NSCLC: The Importance of Liquid Biopsies, Efficacy Data and the Targeted Use of TKI Therapies

  • 328 views
  • April 28, 2021
  • 3
25:38

Stephen Liu

High PD-L1 EGFR+ NSCLC Patient: Molecular Testing & Treatment Options

FEATURING Julie Brahmer, Benjamin Levy
  • 185 views
  • April 20, 2021
15:42

GRACE

Expert Analysis of 1L EGFR+ Advanced NSCLC Options: 1st Gen Gefitinib & Erlotinib, 2nd Gen Afatinib & Dacomitinib, 3rd Gen Osimertinib, Combos With VEGF or Chemo, Exon 20 Insertions

FEATURING Jared Weiss
  • 207 views
  • March 1, 2021
  • 1
20:56

Virtual Evolution: A Conference for Women by Women

Early Stage EGFR+ NSCLC Case Panel Discussion: Adjuvant Osimertinib, Surgical Modalities, and the Role of Adjuvant Chemo/RT

FEATURING Shayma Kazmi, Millie Das, Erin Gillaspie, Katie Keane
  • 292 views
  • December 10, 2020
  • 1
05:03

ecancer

The Role of Adjuvant Therapy in EGFRm Resectable NSCLC: Overview of ADAURA Data

FEATURING Roy Herbst
  • 287 views
  • September 29, 2020
07:56

The Angeles Clinic 2020 ASCO Highlights

ADAURA Data on Stage IB-IIIA EGFR+ NSCLC: What Are the Key Takeaways on Adjuvant Osimertinib After Complete Tumor Resection?

FEATURING Ani Balmanoukian
  • 236 views
  • September 22, 2020

NSCLC Adjuvant Targeted Therapy

No subtopics